ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Johnson & Johnson at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Johnson & Johnson takes part in 4 sessions at ESMO 2026 in Madrid, and exhibits at Booth 1029. Its program centres on personalized cancer treatment, quality of life and precision care in prostate and lung cancers. Topics include data sources for prostate cancer DNA-repair mutations and coordinated care for lung cancer with EGFR mutations.

OrganizationESMO 2026 Attendance
Large pharmaExhibitor
Healthcare company whose Innovative Medicine business markets oncology drugs including amivantamab, daratumumab and teclistamab.
Booth
Exhibiting at Booth 1029 · Johnson & Johnson Innovative Medicine
Satellite
Fri Oct 23
18:15–19:45
Satellite
Sat Oct 24
14:00–15:30
J&J - Collaborative Precision Care in EGFR-mutated NSCLC. A Multidisciplinary Approach
Sponsored session · with ZHAW Zurich University of Applied Sciences
Lung & thoracic cancersNursing & supportive care
Satellite
Sun Oct 25
13:00–14:30
Johnson & Johnson - Transforming the Treatment Journey in EGFR- Mutant NSCLC
Sponsored session · with Maastricht UMC+, European Institute of Oncology (IEO)
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Johnson & Johnson

Tell us what you sell and we’ll find the people at Johnson & Johnson most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction